Clinical Trial Update: ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial ACAPHA, designed to prevent lung cancer in former smokers with bronchial intraepithelial neoplasia, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Intraepithelial Neoplasia
• Lung Cancer

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Lung Cancer, Precancerous Condition | Phase 2 | Status: COMPLETED